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Unimmunized inbred and F, hybrid mice have the ability to reject allogeneic
or parental bone marrow grafts after lethal irradiation (1, 2). The determinants
on the hemopoietic stem cell recognized during marrow rejection have been
termed Hybrid or Hemopoietic histocompatibility (Hh) antigens. The effector
cell mediating marrow graft rejection bears many similarities with the cells
mediating natural killer cell (NK cell) activity (3). However, in attempting to
understand the generation ofthe specificity seen in bone marrow graft rejection,
the conventional view of NK cells as nonspecific killers presents difficulties. NK
cells seem to be improbable mediators of specificity, as they are thought to
recognize as yet undefined target structures on tumor cells or virally infected
cells in an MHC-unrestricted manner (4). It was recently proposed that NK cells
do not use specific receptors, but rather interact with target cells through the
use of Fc receptors and immunoglobulin. Evidence was presented indicating that
the serum of mice contains "natural antibodies" to Hh or to other H-2 antigens
on incompatible marrow cells, which can then bind to stem cells thus rendering
them susceptible to NK cell-mediated antibody dependent cell mediated cyto-
toxicity (ADCC) (5). According to this view then, specificity is not intrinsic to
NK cells but is conferred on them by cell bound antibodies.
To test this hypothesis, we used antibody-deficient C .B-17 scid mice, which are
homozygous for the scid gene and display a severe combined immune deficiency
(SCID) syndrome. They lack both T and B cell functions but display normal NK
activity (6, 7). SCID mice lack detectable circulating immunoglobulins and
therefore any potential "natural antibodies." These mice provide a useful model
to test the hypothesis that antibodies are needed to mediate the specificity seen
in marrow graft rejection by sensitizing stem cells for NK cell-mediated ADCC.
Materials and Methods
Mice.
￿
C.B-17/ICR mice homozygous for the scid mutation, designated C.B-17 scid,
and C.B-17 controls, both H-2°, were kind gifts from Dr. Melvin Bosma of the Institute
for Cancer Research, Philadelphia, PA. The mice were kept in specific pathogen-free
conditions until use. Mice were used at 8-16 wk. C57BL/6 (B6) (H-26), B6D2F1 (H-26/
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H-2d), and DBA/2 (H-2d) mice were bred in a colony at the University of Texas Health
Science Center.
Irradiation.
￿
Recipient mice were exposed to 450-800 cGy of "'Cs gamma radiation
at a dose rate of 85.5 cGy/min. The exposure doses were: SCID mice and C.B-17 mice,
550 cGy; DBA/2 and C57BL/6 mice, 750 cGy; and B6D2F, mice, 800 cGy.
Treatment with Poly(I.C).
￿
Mice in some groups were injected intraperitoneally with 120
jAg of poly(I:C) (P-L Biochemicals, Inc., Milwaukee, WI) I d before marrow cell transfer
to stimulate interferon secretion in order to boost marrow allograft reactivity (3).
Assays for Marrow Cell Proliferation.
￿
The standard assay for proliferation of grafted
hemopoietic cells in lethally irradiated mice has been described previously (1, 2). Briefly,
in the one-step assay, prospective recipient mice were lethally irradiated and infused with
inocula of 4-5 x 106 bone marrow cells (BMC) i.v. The proliferation of donor cells in the
spleens ofrecipients was assessed 5 d later by measuring the incorporation of 5-[125ljiodo-
2'-deoxyuridine (125I-UdR). Each mouse was injected with 10' M fluorodeoxyuridine i.p.
to inhibit endogenous thymidylate synthetase. I h later each mouse was injected with 0.5
'UCi 1251-UdR (Amersham Corp., Arlington Heights, IL). 18 h later, the mice were bled,
sacrificed, and their spleens were removed and placed in counting vials.
12'1 radioactivity
was measured in a well-type gamma counter. The data are presented as the geometric
means (with range of 95% confidence limits) of percentage of injected 1251-UdR incorpo-
rated into spleens of groups of 5-8 mice. Irradiated syngeneic recipients were used to
assess the growth potential of the grafted BMC (syngeneic controls). The spleens of
lethally irradiated mice not injected with BMC retained 0.01-0.03% of the injected
isotope (radiation controls). In two-step experiments, BMC were infused as before into
the lethally irradiated primary recipients. However, at days 5 or 6, the spleens of the
primary hosts were removed and cell suspensions were prepared and washed in RPMI
1640 medium. Secondary irradiated hosts, syngeneic with the original marrow donors,
were infused with inocula of one-fifth spleen cell equivalents. The isotor,e assays were
performed 5-7 d after spleen cell retransplantation as described above. '2 I-UdR uptake
in the secondary hosts reflects the generation of new progenitor cells in the spleen of the
primary hosts (1, 2).
Testing C.B-17 scid Serum for Circulating Immunoglobulin.
￿
Mice were bled from the
lateral tail vein before sacrifice. Serum immunoglobulin levels were kindly determined by
Tracy Stevens in the laboratory of Dr. Ellen Vitetta (Dept. of Microbiology, Univ. of
Texas Health Science Center at Dallas) using an isotope-specific radioimmunoassay, as
described previously (6).
Production of Chimeras.
￿
C.B-17 scid BMC were flushed from the femurs and tibias or
were released by gently crushing the backbone. The cells were suspended in RPMI 1640
medium. Cell suspensions were washed twice and placed on ice at a final concentration of
2 x 107 cells/ml. C57BL/6 mice were treated with 40 ul anti-asialo GM, serum (Wako
Chemicals, Dallas, TX) i.v. to eliminate marrow allograft reactivity (8) and were irradiated
(750 cGy). Within 2 h of irradiation, marrow cells were infused into the lateral tail vein
in a total volume of 0.5 mi. Mice were later tested for chimerism and were used in bone
marrow transplantation experiments 3-4 wk later.
Results
SCID Mice Are Capable ofSpecifically Rejecting Bone Marrow.
￿
A one-step splenic
1251-UdR uptake assay was first performed to examine the ability of SCID mice
to reject the growth of allogeneic BMC grafts. Groups of irradiated H-2d
C.B=17 scid mice were injected with inocula of 5 X 106 H-2b B6 (Hh-Ib-
incompatible), DBA/2 (H-2d-identical but minor Hh-DBA incompatible),
B6D2F 1 (H-2 semiallogeneic but Hh-l-negative) or C.B-17 scid (syngeneic) BMC.
Growth of donor-derived cells was assessed by measuring splenic'2~51-UdR uptake
5 d after cell transfer. SCID mice rejected B6 marrow allografts as indicated by
the low splenic '251-UdR uptake (Fig. 1). Surprisingly, even H-2-identical DBA/2
marrow stem cells, which differ from C.B-17 mice with respect to minor Hh1214
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Donor Host
B6D2F1- B6D2F1
￿
1.25(0.45-3.41)
B6D2F1-
￿
SCID
￿
0.69(0.28- 1 .66)
SCID -
￿
SCID
￿
0.88(0.73-1.05)
DBA/2- DBA/2
￿
1.01(0.72-1 .41)
DBA/2 -
￿
SCID
￿
0.29(0.01-0.80)
B6 -
￿
B6 1
￿
11.79 (0.54- 5.40)
B6-
￿
SCID 1 0.01(0.007-0.03)
0.0 0.4 0.8 1.2 1.6 2.0
Splenic 1251UdR Uptake (%)
Geometric Means (95% C .L .)
FIGURE 1 .
￿
Growth of bone marrow inocula (5 X 10 6 cells) in C.B-17 scid recipients (groups
of five mice, one-step assay) . The DBA/2 and C57BL/6 BMC grew significantly better (P <
0.05) in syngeneic than in SCID hosts, whereas the growth of B6D2F, BMC in syngeneic
recipients was not significantly different from that in SCID hosts .
antigens, were significantly resisted at the inocula given. Both C.B-17 scid and
the Hh-negative B6D2F1 marrow cells proliferated to a similar extent in the
SCID recipients as compared with the level ofgrowth of the marrow in syngeneic
hosts.
Two-step assays were then performed because the assay tends to be more
sensitive than the one-step assay in detecting rejection, and because more param-
eters could be examined with the limited numbers of SCID mice that were
available (Table 1) . In these studies, marrow growth in the primary recipients is
reflected by the 1251-UdR uptake in thesecondary recipients, which are syngeneic
with the original marrow donor. These experiments also demonstrated that
allogeneic B6 marrow grafts can be resisted by SCID primary recipient mice .
Furthermore, it was demonstrated that treatment of the recipient SCID mice
with antisera to asialo-GM, could abrogate resistance to the marrow grafts to a
significant degree . Serum immunoglobulin levels were examined after BMC
transfer . Of the 15 SCID mice used as primary recipients in the two-step
experiments, only three had any detectable immunoglobulins levels, which were
at 0.1% of the normal C.B-17 levels . The IgG2a isotype was never detected ;
however, two SCID mice had 60-140 gg/ml of the IgG3 isotype (1% ofnormal
levels) of the recipients in the two-step assays .
Adoptive Transfer ofMarrow Rejection Specificity UsingSCID --3.B6 Chimeras.
￿
To
examine whether the rejection specificity to BMC grafts could be adoptively
transferred, radiation bone marrow chimeras were created by infusing SCID
mouse marrow cells into irradiated B6 hosts previously treated with anti-asialo-
GM, serum . Such chimeras would be expected to containNK cell activity of the
SCID donor with no donor B orT cell function (9) . Indeed, spleen cells of these
chimeras did not respond to the B cell mitogen, LPS, (mean ± SEM [sH]-
thymidine incprporation (cpm), 0 ± 68 compared to 8,204 ± 3 by normal B6
spleen cells) . Antibody and complement typing of the splenic effector cells in a
NK cell assay against YAC-1 targets revealed that the chimeras possessed NK
cells ofC.B-17 scid (H-2d) donor origin (data not shown) .
SCID ---> B6 marrow chimeras were capable of rejecting host-type B6 (Hh-16)MURPHY ET AL .
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TABLE I
Ability ofIrradiated C.B-17 scid Mice to Reject Allogeneic BoneMarrow Cells
Second-
Marrow donor
￿
Primary recipient
￿
ary re-
￿
Splenic `I-UdR uptake
cipient
* Primary recipient mice in Exp. 1-3 received poly(I :C) on the day of marrow cell transfer .
= Serum immunoglobulin levels were tested by radioimmunoasmy in the 15 primary SCID recipients of Exp . 1-
5 . Three were positive at levels of 0 .1% of control C.B-17 values .
195% confidence limits .
Geometric mean values significantly less (p < 0.05) than syngeneic controls .
Primary recipient mice received asialo-GM, antiserum on the day of marrow transfer.
** Geometric mean values significantly higher (p < 0.05) than without treatment with asialo-GM, antiserum.
marrow grafts as detected by two-step "'I-UdR uptake assays (Table II). Fur-
thermore, this rejection ability could be abrogated by treatment of the recipients
with anti-asialo-GM, serum. These results indicate that Hh-l b-specific marrow
allograft reactivity can be transferred by a stem or progenitor cell source of NK
cells incapable of producing B or T cells.
Discussion
The data presented here demonstrate that irradiated SCID mice are quite
capable of rejecting bone marrow allografts (Fig . 1, Table I) . This provides
direct evidence that the specific rejection of marrow can occur in the absence of
detectable immunoglobulins . Furthermore this ability could be adoptively trans-
ferred by placing SCID bone marrow cells into irradiated C57BL/6 hosts (Table
II) . The fact that SCID --* B6 chimeras rejected B6 (Hh-lb) BMC provides a
powerful argument against the involvement of antibodies in determining the
specificity of marrow allograft reactivity . The B6 mice would not be expected to
have antibodies directed towards self (H-2)-Hh antigens, and the transferred
SCID BMC would not reconstitute the chimera with immunoglobulin-producing
B cells . Thus it appears that the recognition of Hh antigens on B6 stem cells by
C.B-17 scid mice and by SCID --* B6 chimeras would have been accomplished by
C.B-17 scid NK cells, which may possess cell surface anti-Hh-l b receptors .
Whether the putative anti-Hh receptors are present only on a subpopulation of
NK cells or are present on all NK cells remains to be determined . While these
experiments provide strong evidence that immunoglobulin is not required for
Exp .
Strain
Number of
cells grafted
(x 10 6 )
Strain* n Strain Geometric
mean Range}
1 B6 4 B6 3 B6 0.22 0.14-0.32
B6 4 C.B-17 3 B6 0.02 1 0.01-0.03
B6 4 C.B-17scid 3 B6 0.01 1 0.009-0.02
2 B6 4 B6 3 B6 0.19 0.09-0.24
B6 4 C.B-17 3 B6 0.03 1 0.02-0.05
B6 4 C.B-17 scid 3 B6 0.009 , 0.006-0.01
3 B6 4 B6 3 B6 1 .33 0.86-2.06
B6 4 C.B-17 3 B6 0.02 1 0.01-0.03
B6 4 C.B-17 scid 3 B6 0.01 1 0.004-0.05
4 B6 5 B6 1 B6 0.99 0.21-4.66
B6 5 C.B-17 scid 1 B6 0.0081 0.002-0.02
5 B6 5 B6 2 B6 0.42 0.18-0.75
B6 5 C.B-17 scid 2 B6 0.007 1 0.001-0.04
B6 5 C.B-17 scid' 3 B6 0.22** 0.06-0.781216
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TABLE 11
Ability ofC.B-17 scid -rB6 Chimeras to Reject BoneMarrow Allografts
Second-
Marrow donor
￿
Primary recipient
￿
ary re-
￿
Splenic "s-UdR uptake
* Primary recipient mice in experiments 1 and 2 received poly(I:C) 18 h before marrow cell transfer .
= 95% confidence limits .
t Geometric mean values significantly less (p < 0.05) than syngeneic controls .
Primary recipient mice received asialo-GM, antiserum intravenously on day of transfer .
' Geometric mean values significantly higher (p < 0.05) than without treatment with asialo-GM, antiserum .
bonemarrow rejection, they do notrule out the possibility that naturalantibodies
may play some role in normal mice . Certainly, the conventional view of NK cells
as nonspecific effector cells needs to be modified, because these results indicate
that NK cells are capable of distinguishing between self-Hh and foreign Hh (B6,
DBA/2) antigens, and between Hh+ (B6) and Hh- (B6D2F1) stem cells . The
ability of SCID mice to reject BMC also suggests that the receptors used by the
NK cells are not similar to B orT cell receptors, because productive rearrange-
ments ofimmunoglobulin and T cell receptor genes fail to occur in SCID mice
(10) .
It is interesting to note that in the SCID --+ B6 chimeras, the donor SCID NK
cells fail to become tolerized to future marrow grafts of host type, as might have
been expected from previous studies using radiation chimeras (11) . The lack of
tolerance induction may be due to the inability of the SCIDBMC to give rise to
functional T cells. Thus, SCID --* B6 radiation chimeras may also provide some
insight as to the regulatory mechanisms ofmarrow reactivity .
In light of the recent progress in reducing graft-vs.-host disease in human bone
marrow transplantation, solvingthe problem of graft rejection may become very
important in determining the future success of this treatment procedure. Peter
et al . (12) recently reported that haploidentical bone marrow transfers into
human SCID patients resulted in incomplete engraftment in those patients with
NK cell activity . This clinical study suggests that the murine SCID model may
be useful in examining the issues involved in human bone marrow transplanta-
tion .
Summary
C.B-17 scid (H-2d) mice are homozygous for the gene that causes severe
combined immune deficiency (SCID) . These mice have noT or B cell function,
yet display normal natural killer (NK) activity . Irradiated SCID mice were
Exp .
Strain
Number of
cells grafted
(X 106)
Strain n
cipient
Strain Geometric
mean Range*
1 B6 5 B6 1 B6 0.11 0.01-1 .45
B6 5 C.B-17 scid -. B6 1 B6 0.021 0.002-0.36
2 B6 5 B6 2 B6 0.41 0.32-0.65
B6 5 C.B-17 scid- B6 2 B6 0.031 0.008-0.11
3 B6 5 B6 1 B6 1.81 1 .17-2.79
B6 5 C.B-17 scid~ B6 I B6 0 .1 if 0.01-0.80
4 B6 5 B6 2 B6 0.78 0.38-1.62
B6 5 C.B-17 scid --, B6 2 B6 0.094 0.04-0.20
B6 5 C.B-17 scid- B61 2 B6 0.42' 0.24-0.75MURPHY ET AL.
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challenged with marrow grafts to determine if antibodies are necessary for
marrow allograft rejection. SCID mice rejected H-2/Hh-1 allogeneic marrow
grafts. Moreover, this rejection capability could be adoptively transferred using
SCID marrow as a source of NK progenitors infused into irradiated B6 (H-2b)
hosts. We conclude that NK cells can mediate marrow allograft reactivity in the
absence of immunoglobulin. It follows that NK cells probably have specific
receptors for Hh antigens.
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